Novel 7α-alkoxy-17α-(4'-halophenylethynyl)estradiols as potential SPECT/PET imaging agents for estrogen receptor expressing tumours: synthesis and binding affinity evaluation

Steroids. 2012 Sep;77(11):1123-32. doi: 10.1016/j.steroids.2012.05.004. Epub 2012 May 24.

Abstract

In order to develop potential radiolabelled probes for imaging estrogen receptor (ER) positive tumours, we have synthesized and characterized a series of novel 7α-alkoxy-17α-(4'-iodophenylethynyl)estra-1,3,5(10)-triene-3,17β-diols and 7α-alkoxy-17α-(4'-fluorophenylethynyl)estra-1,3,5(10)-triene-3,17β-diols. The fluoro-substituted compounds showed a higher ER binding affinity than the corresponding iodo-derivatives, where 7α-methoxy- and 17α-(4'-fluorophenylethynyl)estra-1,3,5(10)-triene-3,17β-diol showed the highest ER binding affinities (RBA=80.9% and 78.9%, respectively), among the halophenylethynyl compounds studied and should be further explored as potential PET biomarkers for imaging of ER expressing tumours.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / diagnosis*
  • Estradiol / analogs & derivatives*
  • Estradiol / chemical synthesis*
  • Estradiol / chemistry
  • Estrogen Receptor alpha / chemistry*
  • Female
  • Fluorine
  • Humans
  • Iodine
  • Magnetic Resonance Spectroscopy
  • Neoplasms, Hormone-Dependent / diagnosis*
  • Positron-Emission Tomography
  • Recombinant Proteins / chemistry
  • Structure-Activity Relationship
  • Tomography, Emission-Computed, Single-Photon

Substances

  • Estrogen Receptor alpha
  • Recombinant Proteins
  • Fluorine
  • Estradiol
  • Iodine